described in research write-ups, not clinical trials
Second, its a colossal waste of resources
Areas of Scientific Interest Research involving BPC-157 has explored: Cellular signalling pathways Angiogenesis-related mechanisms Connective tissue biology Gastrointestinal research Vascular response systems As with all research compounds, BPC-157 is intended exclusively for laboratory and scientific research purposes
So, with a mild background noise of familiar anxiety, I retrieved the supplies, washed my hands and then pulled opened the insulin specific needle-syringe combination packaging, tore open two swabs then laid it all out on a clean surface
Biological Activity Cagrilintide and semaglutide, when co-administered, produce synergistic reductions in bodyweight (up to ~1517% over 2032 weeks in clinical trials) and significant improvements in glycemic parameters, including HbA1c and fasting glucose
Applied twice daily using 0.5ml per application, this provides 20mg per day of topical peptide (though actual absorption is much lower due to skin penetration limits)